Epstein-Barr virus infection in urothelial transitional cell carcinoma tissues

BJU International

Volumn 93, Issue 4, 2004, Pages 495-498

  Chuang, C K ^a   Liao, S K ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Epstein Barr virus; Hybridization; Pathogenesis; Transitional cell carcinoma

Indexed keywords

CD20 ANTIBODY; LATENT MEMBRANE PROTEIN 1; VIRUS RNA;

ARTICLE; B LYMPHOCYTE; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DNA PROBE; EPSTEIN BARR VIRUS; HUMAN; HUMAN TISSUE; HYBRIDIZATION; IMMUNOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; ONCOGENE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; TRANSITIONAL CELL CARCINOMA; TUMOR CELL; TUMOR SUPPRESSOR GENE; UROGENITAL TRACT TUMOR; VIRUS INFECTION; GENE ACTIVATION; GENE MUTATION; UROGENITAL TRACT CANCER;

CARCINOMA, TRANSITIONAL CELL; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; RNA, VIRAL; UROLOGIC NEOPLASMS;

EID: 1642411727     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2003.04687.x     Document Type: Article

References (23)

1. Reznikoff CA, Kao C, Messing EM, Newton M, Swaminathan S. A molecular genetic model of human bladder carcinogenesis. Sem Can Biol 1993; 4: 143-52
2. Koffa M, Koumantakis E, Ergazaki M, Tsatsanis C, Spandidos DA. Association of herpesvirus infection with the development of genital cancer. Int J Cancer 1995; 63: 58-62
3. Henle W, Henle G. Epstein-Barr virus and human malignancies. Cancer 1974; 34: 1368-74
4. Miller G. Epstein-Barr virus biology, pathogenesis and medical aspects. In Fields BN, Knip DM eds, Virology. New York: Raven Press, 1990: 1921-57
5. Niedobitek G, Young LS. Epstein-Barr virus persistence and virus-associated tumors. Lancet 1994; 343: 333-5
6. Chao TY, Chow KC, Chang JY et al. Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma. Cancer 1996; 78: 24-9
7. Tomita Y, Ohsawa M, Kanno H et al. Epstein-Barr virus in Hodgkin's disease patients in Japan. Cancer 1996; 77: 186-92
8. Brichacek B, Hirsch I, Sibl O, Vilikusova E, Vonka V. Presence of Epstein-Barr virus DNA in carcinomas of the palatine tonsil. J Nat Can Ins 1984; 72: 809-15
9. Kiaris H, Ergazaki M, Segas J, Spandidos DA. Detection of Epstein-Barr virus genome in squamous cell carcinomas of the larynx. Int J Biol Markers 1995; 10: 211-5
10. Nagao T, Ishida Y, Sugano I et al. Epstein-Barr virus-associated undifferentiated carcinoma with lymphoid stroma of the salivary gland in Japanese patients. Comparison with benign lymphoepithelial lesions. Cancer 1996; 78: 695-703
11. Imai S, Koizumi S, Sugima M et al. Gastric carcinoma monoclonal epithelial cells expressing Epstein-Barr virus late infection protein. Proc Natl Acad Sci USA 1994; 91: 9131-5
12. Higashiyama M, Doi O, Kodama K et al. Lymphoepithelioma-like carcinoma of the lung: analysis of two cases for Epstein-Barr virus infection. Hum Pathol 1995; 26: 1278-82
13. Gazzaniga P, Vercillo R, Gradilone A et al. Prevalence of papillomavirus, Epstein-Barr virus, cytomegalovirus, and herpes simplex virus type 2 in urinary bladder cancer. J Med Virol 1998; 55: 262-7
14. Chuang C-K, Liao S-K. Expression of Epstein-Barr virus-encoded RNA in a renal pelvic transitional cell carcinoma. BJU Int 2000; 86: 905-7
15. Chuang C-K, Shen Y-C, Chow K-C, Chang KSS, Liao S-K. An Epstein-Barr virus-carrying cell line derived from B lymphocytes-infiltrating renal pelvis transitional cell carcinoma with expression of a cytogenetic marker dup (2) (p13p25). Proc Am Ass Cancer Res 1999; 40: 445
16. Gregory CD, Dive C, Henderson S et al. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature (London) 1991; 349: 612-4
17. Reed JC, Halder S, Cuddy MP, Croce CM, Makover D. Deregulated bcl-2 expression enhances growth of a human B cell line. Oncogene 1989; 4: 1123-7
18. Li SN, Chang YS, Liu ST. Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus. Oncogene 1996; 12: 2129-35
19. Chang Y-S, Su I-J, Chung P-J et al. Detection of an Epstein-Barr virus variant in T-cell lymphoma tissues identical to the distinct strain observed in nasopharyngeal carcinoma in the Taiwanese population. Int J Cancer 1995; 62: 673-7
20. Chen M-L, Tsai C-N, Liang C-L et al. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in Taiwanese population. Oncogene 1992; 7: 2131-40
21. Imai S, Nishkawa J, Takada K. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol 1989; 72: 4371-8
22. Bayliss GJ, Wolf H. Epstein-Barr virus induced cell fusion. Nature (London) 1980; 287: 164-5
23. Lin C-T, Lin C-R, Tan G-K et al. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells. Am J Pathol 1997; 150: 1745-56